- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05779410
Vitamin D in Healthy Adults After Strenuous Endurance Exercise
March 9, 2023 updated by: Taipei Medical University
Effects of Vitamin D Supplementation on Biochemical Responses and Aerobic Capacity After Strenuous Endurance Exercise
The purpose of this study was to investigate the effects of vitamin D supplementation on biochemical response and aerobic capacity after strenuous endurance exercise (SEE).
Study Overview
Status
Completed
Conditions
Intervention / Treatment
Detailed Description
All participants conducted a graded exercise test on an ergometric bicycle to determine the maximal oxygen consumption (VO2max) before and after supplementation, and the speed equivalent to 65% VO2max was conducted for a SEE test by ergometric bicycle for 2 hours, followed by increasing 100 RPM until exhaustion.
Venous blood samples were drawn before, immediately after, 2-hour after, 4-hour after, 8-hour after, and 24-hour after the SEE test to determine the concentrations of biomarkers.
Data was analyzed by Two-way mixed design ANOVA.
Study Type
Interventional
Enrollment (Actual)
35
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Taipei, Taiwan, 110
- Taipei Medical University
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
20 years to 40 years (Adult)
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
Male
Description
Inclusion Criteria:
The volunteers included have conditions as stated below :
- no history of cardiovascular, liver, kidney and diabetes disease
- no acute sport injury
- male adult whose concentration of 25(OH)D is under 30 ng/mL, and maximal oxygen consumption is over 40 ml/kg/min
- did not participated in any clinical trials or research in the last 3 months before our experiment
- no supplements were taken during the experimental period
- were requested to maintain their regular daily life style and avoid alcohol intake
Exclusion Criteria:
The volunteers were excluded if they have the situation stated below:
- history of cardiovascular, liver, kidney and diabetes disease
- acute sport injury
- their concentration of 25(OH)D is over 30 ng/mL, or maximal oxygen consumption is under 40 ml/kg/min
- participated in any clinical trials or experimental research in the last 3 months before our experiment
- taking supplement during the experimental period
- did not maintain their regular eating habit or drink alcohol
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Treatment
- Allocation: Non-Randomized
- Interventional Model: Parallel Assignment
- Masking: Double
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Placebo Comparator: Placebo group
|
Participants received the same amount of placebo matching vitamin D orally twice daily for 4 weeks
|
|
Experimental: Vitamin D group
|
Participants received 5,000 IU of vitamin D orally twice daily for 4 weeks
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Time Frame |
|---|---|
|
Concentration of lymphocyte
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of lymphocyte
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of lymphocyte
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of lymphocyte
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of CD4+
Time Frame: before exercise
|
before exercise
|
|
Concentration of CD4+
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of CD4+
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of CD4+
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of CD4+
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of CD8+
Time Frame: before exercise
|
before exercise
|
|
Concentration of CD8+
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of CD8+
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of CD8+
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of CD8+
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of CD19+
Time Frame: before exercise
|
before exercise
|
|
Concentration of CD19+
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of CD19+
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of CD19+
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of CD19+
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of CD56+
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of CD56+
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of CD56+
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of CD56+
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of TNF-α
Time Frame: before exercise
|
before exercise
|
|
Concentration of TNF-α
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of TNF-α
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of TNF-α
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of TNF-α
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of IL-1β
Time Frame: before exercise
|
before exercise
|
|
Concentration of IL-1β
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of IL-1β
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of IL-1β
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of IL-1β
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of IFN-γ
Time Frame: before exercise
|
before exercise
|
|
Concentration of IFN-γ
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of IFN-γ
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of IFN-γ
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of IFN-γ
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of IL-2
Time Frame: before exercise
|
before exercise
|
|
Concentration of IL-2
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of IL-2
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of IL-2
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of IL-2
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of IL-4
Time Frame: before exercise
|
before exercise
|
|
Concentration of IL-4
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of IL-4
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of IL-4
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of IL-4
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of IL-8
Time Frame: before exercise
|
before exercise
|
|
Concentration of IL-8
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of IL-8
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of IL-8
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of IL-8
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of IL-10
Time Frame: before exercise
|
before exercise
|
|
Concentration of IL-10
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of IL-10
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of IL-10
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of IL-10
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of TBARS
Time Frame: before exercise
|
before exercise
|
|
Concentration of TBARS
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of TBARS
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of TBARS
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of TBARS
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of PC
Time Frame: before exercise
|
before exercise
|
|
Concentration of PC
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of PC
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of PC
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of PC
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of SOD
Time Frame: before exercise
|
before exercise
|
|
Concentration of SOD
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of SOD
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of SOD
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of SOD
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of catalase
Time Frame: before exercise
|
before exercise
|
|
Concentration of catalase
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of catalase
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of catalase
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of catalase
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of GPx
Time Frame: before exercise
|
before exercise
|
|
Concentration of GPx
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of GPx
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of GPx
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of GPx
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of CK
Time Frame: before exercise
|
before exercise
|
|
Concentration of CK
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of CK
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of CK
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of CK
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of LDH
Time Frame: before exercise
|
before exercise
|
|
Concentration of LDH
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of LDH
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of LDH
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of LDH
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of IL-6
Time Frame: before exercise
|
before exercise
|
|
Concentration of IL-6
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of IL-6
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of IL-6
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of IL-6
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of Neutrophil
Time Frame: before exercise
|
before exercise
|
|
Concentration ofNeutrophil
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of Neutrophil
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of Neutrophil
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of Neutrophil
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of Neutrophil
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of eosinophil
Time Frame: before exercise
|
before exercise
|
|
Concentration of eosinophil
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of eosinophil
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of eosinophil
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of eosinophil
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of eosinophil
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of basophil
Time Frame: before exercise
|
before exercise
|
|
Concentration of basophil
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of basophil
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of basophil
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of basophil
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of basophil
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of monocyte
Time Frame: before exercise
|
before exercise
|
|
Concentration of monocyte
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of monocyte
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of monocyte
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of monocyte
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of monocyte
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of lymphocyte
Time Frame: before exercise
|
before exercise
|
|
Concentration of lymphocyte
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of CD4+
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of CD8+
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of CD19+
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of CD56+
Time Frame: before exercise
|
before exercise
|
|
Concentration of CD56+
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of IgA
Time Frame: before exercise
|
before exercise
|
|
Concentration of IgA
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of IgA
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of IgA
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of IgA
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of IgA
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of Cathelicidin
Time Frame: before exercise
|
before exercise
|
|
Concentration of Cathelicidin
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of Cathelicidin
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of Cathelicidin
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of Cathelicidin
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of Cathelicidin
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
|
Concentration of TNF-α
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of IL-1β
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of IFN-γ
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of IL-2
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of IL-4
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of IL-8
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of IL-10
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of TBARS
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of PC
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of SOD
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of catalase
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of GPx
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of CK
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of LDH
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of IL-6
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of CRP
Time Frame: before exercise
|
before exercise
|
|
Concentration of CRP
Time Frame: immediately after exercise
|
immediately after exercise
|
|
Concentration of CRP
Time Frame: 2-hour after exercise
|
2-hour after exercise
|
|
Concentration of CRP
Time Frame: 4-hour after exercise
|
4-hour after exercise
|
|
Concentration of CRP
Time Frame: 8-hour after exercise
|
8-hour after exercise
|
|
Concentration of CRP
Time Frame: 24-hour after exercise
|
24-hour after exercise
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
January 20, 2021
Primary Completion (Actual)
December 8, 2021
Study Completion (Actual)
December 8, 2021
Study Registration Dates
First Submitted
February 20, 2023
First Submitted That Met QC Criteria
March 9, 2023
First Posted (Actual)
March 22, 2023
Study Record Updates
Last Update Posted (Actual)
March 22, 2023
Last Update Submitted That Met QC Criteria
March 9, 2023
Last Verified
February 1, 2023
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- N202010026
- A-107-077 (Other Grant/Funding Number: Panion & BF Biotech Inc.)
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Healthy
-
University of Vermont Medical CenterAvocado Nutrition CenterRecruitingHealthy | Healthy Volunteers | Healthy Subjects | Healthy Volunteer | Healthy Adult | Healthy Volunteers Only | Healthy Male and Female Subjects | Healthy Non-smokersUnited States
-
Dragonfly TherapeuticsRecruitingHealthy | Healthy Participants | Healthy Adult Females | Volunteer | Healthy Adult MaleAustralia
-
University of PalermoCompletedHealthy | Healthy Volunteers | Healthy Subjects | Healthy Participants | Static Stretching | Stretch | StretchingItaly
-
Prevent Age Resort "Pervaya Liniya"RecruitingHealthy Aging | Healthy Diet | Healthy LifestyleRussian Federation
-
Umm Al-Qura UniversityActive, not recruitingHealthy | Healthy Participants | Healthy Adult | Healthy Women | Healthy Adult Females | Healthy Adult Participants | Healthy Young Adults | Healthy Adult Female Participants | Healthy Adult Male | Poor Sleep Quality | Healthy (Controls) | Poor Sleeping Quality | Healthy Adult Male Subjects | Health Adult SubjectsSaudi Arabia
-
Maastricht University Medical CenterCompletedHealthy Volunteers | Healthy Subjects | Healthy AdultsNetherlands
-
University of PalermoCompletedHealthy Participants | Healthy Adult Participants | Healthy Young AdultsItaly
-
Yale UniversityNot yet recruitingHealth-related Benefits of Introducing Table Olives Into the Diet of Young Adults: Olives For HealthHealthy Diet | Healthy Lifestyle | Healthy Nutrition | CholesterolUnited States
-
PfizerNot yet recruitingHealthy | Healthy AdultsUnited States
-
Atisama TherapeuticsRecruitingHealthy | Healthy SmokerAustralia
Clinical Trials on Vitamin D
-
University of Ilorin Teaching HospitalMayo ClinicNot yet recruitingProstate Cancer (Adenocarcinoma) | Vitamin D on Tumor Response and Inflammatory MarkersNigeria
-
PfizerTerminated
-
Wroclaw University of Health and Sport SciencesCompletedAthletes | Football Players | Exercise Physiology | Vitamin D Deficiency (10 ng/mL to 30 ng/mL)Poland
-
Universidad Autónoma Benito Juárez de OaxacaNational Council of Science and Technology, MexicoCompletedObesity | Muscle Weakness | Vitamin D Deficiency | Sarcopenia | Aging | Sarcopenic Obesity | Obesity (Disorder) | Sarcopenia in Elderly | Muscle Mass | Functional Decline | Age-Related Loss of Skeletal Muscle Mass | Older Adults (65 Years and Older) | Muscle Strengh | Vitamin D 25-Hydroxylase DeficiencyMexico
-
Umeå UniversityRegion SkaneCompleted
-
Bangladesh Medical UniversityEnrolling by invitationHypovitaminosis D | Major Depressive Disorder (MDD)Bangladesh
-
Karadeniz Technical UniversityActive, not recruitingThose Who Provided Written Informed Consent | Female Gender | Aged 18 Years and Older | Hypothyroidism Disease | Serum Vitamin d < 30 ng/dlTurkey (Türkiye)
-
Khon Kaen UniversityCompletedEndometriosis | Vitamin D Status | Vitamin D Deficiency/InsufficiencyThailand
-
Fundación Cardiovascular de ColombiaUniversidad Industrial de Santander; Farma de Colombia SACompletedVitamin D Deficiency | Overweight and Obesity | Overweight AdolescentsColombia
-
Bursa City HospitalCompletedVitamin D Deficiency | COVIDTurkey (Türkiye)